The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (α-MSH) therapy

Brain, Behavior, and Immunity

Volumn 22, Issue 5, 2008, Pages 639-646

  Taylor, Andrew W ^a   Kitaichi, Nobuyoshi ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Alpha melanocyte stimulating hormone; Autoimmune disease; Experimental autoimmune encephalomyelitis; Immunosuppression; Neuroimmunology; Neuroimmunomodulation; Neuropeptide therapy; Regulatory immunity

Indexed keywords

ALPHA INTERMEDIN; AUTOANTIGEN; NEUROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; IMMUNOLOGICAL TOLERANCE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE DRUG DOSE; SPLEEN CELL;

ALPHA-MSH; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; NEUROIMMUNOMODULATION; PEPTIDE FRAGMENTS; PROTEOLIPIDS; SPLEEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 44849128371     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.11.001     Document Type: Review

References (59)

1. Bohm M., and Luger T.A. Melanocortins in fibroblast biology-current update and future perspective for dermatology. Exp. Dermatol. 13 Suppl. 4 (2004) 16-21
2. Bohm M., Wolff I., Scholzen T.E., Robinson S.J., Healy E., Luger T.A., Schwarz T., and Schwarz A. Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280 (2005) 5795-5802
3. Brzoska T., Kalden D.H., Scholzen T., and Luger T.A. Molecular basis of the alpha-MSH/IL-1 antagonism. Ann. NY Acad. Sci. 885 (1999) 230-238
4. Butler A.A., and Cone R.D. The melanocortin receptors: lessons from knockout models. Neuropeptides 36 (2002) 77-84
5. Ceriani G., Diaz J., Murphree S., Catania A., and Lipton J.M. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1 (1994) 28-32
6. Chakraborty A.K., Funasaka Y., Slominski A., Ermak G., Hwang J., Pawelek J.M., and Ichihashi M. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313 (1996) 130-138
7. Dasgupta S., Jana M., Zhou Y., Fung Y.K., Ghosh S., and Pahan K. Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis. J. Immunol. 173 (2004) 1344-1354
8. de Jong B.A., Westendorp R.G., Eskdale J., Uitdehaag B.M., and Huizinga T.W. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum. Immunol. 63 (2002) 281-285
9. Falk K., Rotzschke O., Santambrogio L., Dorf M.E., Brosnan C., and Strominger J.L. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides. J. Exp. Med. 191 (2000) 717-730
10. Glyn J.R., and Lipton J.M. Hypothermic and antipyretic effects of centrally administered ACTH (1-24) and alpha-melanotropin. Peptides 2 (1981) 177-187
11. Grabbe S., Bhardwaj R.S., Mahnke K., Simon M.M., Schwarz T., and Luger T.A. Alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156 (1996) 473-478
12. Han D., Tian Y., Zhang M., Zhou Z., and Lu J. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther. 14 (2007) 383-395
13. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., and Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237 (2005) 123-130
14. Holdeman M., Khorram O., Samson W.K., and Lipton J.M. Fever-specific changes in central MSH and CRF concentrations. Am. J. Physiol. 248 (1985) R125-R129
15. Jahovic N., Arbak S., Tekeli O., and Alican I. Alpha-melanocyte stimulating hormone has beneficial effects on cerulein-induced acute pancreatitis. Peptides 25 (2004) 129-132
16. Karpus W.J., and Ransohoff R.M. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161 (1998) 2667-2671
17. Kennedy M.K., Torrance D.S., Picha K.S., and Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149 (1992) 2496-2505
18. Kitaichi N., Namba K., and Taylor A.W. Inducible immune regulation following autoimmune disease in the immune-privileged eye. J. Leukoc. Biol. 77 (2005) 496-502
19. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., and Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 566-573
20. Kono D.H., Urban J.L., Horvath S.J., Ando D.G., Saavedra R.A., and Hood L. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J. Exp. Med. 168 (1988) 213-227
21. Kroenke M.A., and Segal B.M. Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 85 (2007) 1685-1693
22. Lam C.W., Perretti M., and Getting S.J. Melanocortin receptor signaling in RAW264.7 macrophage cell line. Peptides 27 (2006) 404-412
23. Lee T.H., Lerner A.B., and Buettner-Janusch V. The isolation and structure of α- and β-melanocyte-stimulating hormones from monkey pituitary glands. J. Biol. Chem. 236 (1961) 1390-1394
24. Lipton J.M., and Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today 18 (1997) 140-145
25. Lohr J., Knoechel B., Wang J.J., Villarino A.V., and Abbas A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 203 (2006) 2785-2791
26. Luger T.A., Kalden D., Scholzen T.E., and Brzoska T. Alpha-melanocyte-stimulating hormone as a mediator of tolerance induction. Pathobiology 67 (1999) 318-321
27. Mann C.L., Davies M.B., Stevenson V.L., Leary S.M., Boggild M.D., Ko Ko C., Jones P.W., Fryer A.A., Strange R.C., Thompson A.J., and Hawkins C.P. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J. Neuroimmunol. 129 (2002) 197-204
28. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161 (1998) 2873-2880
29. Martin L.W., and Lipton J.M. Acute phase response to endotoxin: rise in plasma alpha-MSH and effects of alpha-MSH injection. Am. J. Physiol. 259 (1990) R768-R772
30. Namba K., Kitaichi N., Nishida T., and Taylor A.W. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J. Leukoc. Biol. 72 (2002) 946-952
31. Nishida T., Miyata S., Itoh Y., Mizuki N., Ohgami K., Shiratori K., Ilieva I.B., Ohno S., and Taylor A.W. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int. Immunopharmacol. 4 (2004) 1059-1066
32. Nishida T., and Taylor A.W. Specific aqueous humor factors induce activation of regulatory T cells. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2268-2274
33. Partridge J.M., Weatherby S.J., Woolmore J.A., Highland D.J., Fryer A.A., Mann C.L., Boggild M.D., Ollier W.E., Strange R.C., and Hawkins C.P. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 62 (2004) 2323-2325
34. Raap U., Brzoska T., Sohl S., Path G., Emmel J., Herz U., Braun A., Luger T., and Renz H. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J. Immunol. 171 (2003) 353-359
35. Rees J.L. Genetics of hair and skin color. Annu. Rev. Genet. 37 (2003) 67-90
36. Sarkar A., Sreenivasan Y., and Manna S.K. Alpha-melanocyte-stimulating hormone induces cell death in mast cells: involvement of NF-kappaB. FEBS Lett. 549 (2003) 87-93
37. Shiratori K., Ohgami K., Ilieva I.B., Koyama Y., Yoshida K., and Ohno S. Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by alpha-melanocyte-stimulating hormone. Invest. Ophthalmol. Vis. Sci. 45 (2004) 159-164
38. Sobel R.A., Tuohy V.K., Lu Z.J., Laursen R.A., and Lees M.B. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropathol. Exp. Neurol. 49 (1990) 468-479
39. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., and Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 92 (1995) 8016-8020
40. Streilein J.W. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 74 (2003) 179-185
41. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3 (2003) 879-889
42. Taherzadeh S., Sharma S., Chhajlani V., Gantz I., Rajora N., Demitri M.T., Kelly L., Zhao H., Ichiyama T., Catania A., and Lipton J.M. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am. J. Physiol. 276 (1999) R1289-R1294
43. Taylor A. A review of the influence of aqueous humor on immunity. Ocul. Immunol. Inflamm. 11 (2003) 231-241
44. Taylor A., and Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell Biol. 79 (2001) 358-367
45. Taylor A.W. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 143-149
46. Taylor A.W. The immunomodulating neuropeptide alpha-melanocyte stimulating hormone (a-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J. Neuroimmunol. 162 (2005) 43-50
47. Taylor A.W. Ocular immunosuppressive microenvironment. Chem. Immunol. Allergy 92 (2007) 71-85
48. Taylor A.W., Alard P., Yee D.G., and Streilein J.W. Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr. Eye Res. 16 (1997) 900-908
49. Taylor A.W., Kitaichi N., and Biros D. Melanocortin 5 receptor and ocular immunity. Cell Mol. Biol. 52 (2006) 141-147
50. Taylor A.W., and Streilein J.W. Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation 3 (1996) 112-118
51. Taylor A.W., Streilein J.W., and Cousins S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11 (1992) 1199-1206
52. Taylor A.W., Streilein J.W., and Cousins S.W. Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1 (1994) 188-194
53. Taylor A.W., Yee D.G., Nishida T., and Namba K. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann. NY Acad. Sci. 917 (2000) 239-247
54. Tung Y.C., Piper S.J., Yeung D., O'Rahilly S., and Coll A.P. A comparative study of the central effects of specific POMC-derived melanocortin peptides on food intake and body weight in Pomc null mice. Endocrinology (2006)
55. Villar M., Perassi N., and Celis M.E. Central and peripheral actions of alpha-MSH in the thermoregulation of rats. Peptides 12 (1991) 1441-1443
56. Wang C.H., Jawan B., Lee T.H., Hung K.S., Chou W.Y., Lu C.N., Liu J.K., and Chen Y.J. Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice. Biochem. Biophys. Res. Commun. 322 (2004) 153-161
57. Weinshenker B.G., Hebrink D., Kantarci O.H., Schaefer-Klein J., Atkinson E., Schaid D., and McMurray C.M. Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis. J. Neuroimmunol. 120 (2001) 138-145
58. Yin P., Luby T.M., Chen H., Etemad-Moghadam B., Lee D., Aziz N., Ramstedt U., and Hedley M.L. Generation of expression constructs that secrete bioactive alphaMSH and their use in the treatment of experimental autoimmune encephalomyelitis. Gene Ther. 10 (2003) 348-355
59. Yoon S.W., Goh S.H., Chun J.S., Cho E.W., Lee M.K., Kim K.L., Kim J.J., Kim C.J., and Poo H. Alpha-melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J. Biol. Chem. 278 (2003) 32914-32920